Bio-Rad Laboratories Inventory Turnover Ratio 2010-2025 | BIO

Current and historical inventory turnover ratio for Bio-Rad Laboratories (BIO) from 2010 to 2025. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Bio-Rad Laboratories inventory turnover ratio for the three months ending March 31, 2025 was 0.35.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.705B $2.567B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $215.166B 25.24
Boston Scientific (BSX) United States $153.330B 38.38
Stryker (SYK) United States $148.630B 31.08
EssilorLuxottica (ESLOY) France $131.070B 0.00
Medtronic (MDT) Ireland $114.929B 16.29
Lonza Group Ag (LZAGY) Switzerland $49.764B 0.00
Haleon (HLN) United Kingdom $43.126B 24.61
ResMed (RMD) United States $37.818B 28.41
GE HealthCare Technologies (GEHC) United States $34.781B 16.51
Agilent Technologies (A) United States $32.381B 21.11
Terumo (TRUMY) Japan $23.911B 31.06
Koninklijke Philips (PHG) Netherlands $23.688B 16.62
Insulet (PODD) United States $20.003B 78.52
Zimmer Biomet Holdings (ZBH) United States $18.437B 11.84
Baxter (BAX) United States $14.251B 10.64
Smith & Nephew SNATS (SNN) United Kingdom $13.214B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Lantheus Holdings (LNTH) United States $4.855B 12.25
Prestige Consumer Healthcare (PBH) United States $3.744B 16.73
Perrigo (PRGO) Ireland $3.706B 9.39
Haemonetics (HAE) United States $3.485B 15.88
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.307B 27.48
ICU Medical (ICUI) United States $3.014B 22.23
LeMaitre Vascular (LMAT) United States $1.802B 40.29
QuidelOrtho (QDEL) United States $1.721B 11.84
AtriCure (ATRC) United States $1.449B 0.00
Acuren (TIC) United States $1.408B 0.00
AdaptHealth (AHCO) United States $1.244B 12.63
Phibro Animal Health (PAHC) United States $1.192B 15.24
Green Thumb Industries (GTBIF) United States $1.190B 26.76
Neogen (NEOG) United States $1.029B 13.17
BioLife Solutions (BLFS) United States $0.996B 0.00
InMode (INMD) Israel $0.878B 8.85
Kestra Medical Technologies (KMTS) United States $0.816B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Tilray Brands (TLRY) Canada $0.625B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.619B 0.00
Owens & Minor (OMI) United States $0.599B 4.97
Evolus (EOLS) United States $0.593B 0.00
CeriBell (CBLL) United States $0.563B 0.00
Valneva SE (VALN) France $0.557B 0.00
Surmodics (SRDX) United States $0.432B 0.00
SNDL (SNDL) Canada $0.405B 0.00
Sanuwave Health (SNWV) United States $0.336B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.315B 0.00
Capricor Therapeutics (CAPR) United States $0.314B 0.00
VAREX IMAGING (VREX) United States $0.298B 10.97
Quanterix (QTRX) United States $0.268B 0.00
Cresco Labs (CRLBF) United States $0.267B 0.00
Cerus (CERS) United States $0.260B 0.00
Viemed Healthcare (VMD) United States $0.257B 21.63
Aurora Cannabis (ACB) Canada $0.255B 75.50
OraSure Technologies (OSUR) United States $0.239B 0.00
ZimVie (ZIMV) United States $0.235B 10.68
Sanara MedTech (SMTI) United States $0.234B 0.00
Brainsway (BWAY) Israel $0.228B 60.45
Biote (BTMD) United States $0.220B 6.18
Canopy Growth (CGC) Canada $0.200B 0.00
High Tide (HITI) Canada $0.199B 0.00
Omeros (OMER) United States $0.197B 0.00
Verano Holdings (VRNOF) United States $0.195B 0.00
Organigram Global (OGI) Canada $0.194B 0.00
Utah Medical Products (UTMD) United States $0.180B 14.69
TriSalus Life Sciences (TLSI) United States $0.174B 0.00
Vireo Growth (VREOF) United States $0.149B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.120B 0.00
TerrAscend (TSNDF) Canada $0.110B 0.00
Jin Medical (ZJYL) China $0.103B 0.00
Fonar (FONR) United States $0.099B 12.80
MacroGenics (MGNX) United States $0.093B 0.00
Quipt Home Medical (QIPT) United States $0.091B 0.00
Veru (VERU) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.085B 0.00
Jushi Holdings (JUSHF) United States $0.076B 0.00
Zynex (ZYXI) United States $0.070B 0.00
InterCure (INCR) Israel $0.069B 0.00
Agape ATP (ATPC) $0.065B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Safety Shot (SHOT) United States $0.055B 0.00
United-Guardian (UG) United States $0.042B 14.52
Nephros (NEPH) United States $0.039B 52.07
Rockwell Medical (RMTI) United States $0.038B 0.00
Modular Medical (MODD) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00